Cargando…

Comment on: Meagher et al. Neutralization of Interleukin-16 Protects Nonobese Diabetic Mice From Autoimmune Type 1 Diabetes by a CCL4-Dependent Mechanism. Diabetes 2010;59:2862–2871

Detalles Bibliográficos
Autores principales: Vendrame, Francesco, Dotta, Francesco
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3028376/
https://www.ncbi.nlm.nih.gov/pubmed/21270245
http://dx.doi.org/10.2337/db10-1489
_version_ 1782197175212572672
author Vendrame, Francesco
Dotta, Francesco
author_facet Vendrame, Francesco
Dotta, Francesco
author_sort Vendrame, Francesco
collection PubMed
description
format Text
id pubmed-3028376
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-30283762012-02-01 Comment on: Meagher et al. Neutralization of Interleukin-16 Protects Nonobese Diabetic Mice From Autoimmune Type 1 Diabetes by a CCL4-Dependent Mechanism. Diabetes 2010;59:2862–2871 Vendrame, Francesco Dotta, Francesco Diabetes Online Letters To The Editor American Diabetes Association 2011-02 2011-01-21 /pmc/articles/PMC3028376/ /pubmed/21270245 http://dx.doi.org/10.2337/db10-1489 Text en © 2011 by the American Diabetes Association.
spellingShingle Online Letters To The Editor
Vendrame, Francesco
Dotta, Francesco
Comment on: Meagher et al. Neutralization of Interleukin-16 Protects Nonobese Diabetic Mice From Autoimmune Type 1 Diabetes by a CCL4-Dependent Mechanism. Diabetes 2010;59:2862–2871
title Comment on: Meagher et al. Neutralization of Interleukin-16 Protects Nonobese Diabetic Mice From Autoimmune Type 1 Diabetes by a CCL4-Dependent Mechanism. Diabetes 2010;59:2862–2871
title_full Comment on: Meagher et al. Neutralization of Interleukin-16 Protects Nonobese Diabetic Mice From Autoimmune Type 1 Diabetes by a CCL4-Dependent Mechanism. Diabetes 2010;59:2862–2871
title_fullStr Comment on: Meagher et al. Neutralization of Interleukin-16 Protects Nonobese Diabetic Mice From Autoimmune Type 1 Diabetes by a CCL4-Dependent Mechanism. Diabetes 2010;59:2862–2871
title_full_unstemmed Comment on: Meagher et al. Neutralization of Interleukin-16 Protects Nonobese Diabetic Mice From Autoimmune Type 1 Diabetes by a CCL4-Dependent Mechanism. Diabetes 2010;59:2862–2871
title_short Comment on: Meagher et al. Neutralization of Interleukin-16 Protects Nonobese Diabetic Mice From Autoimmune Type 1 Diabetes by a CCL4-Dependent Mechanism. Diabetes 2010;59:2862–2871
title_sort comment on: meagher et al. neutralization of interleukin-16 protects nonobese diabetic mice from autoimmune type 1 diabetes by a ccl4-dependent mechanism. diabetes 2010;59:2862–2871
topic Online Letters To The Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3028376/
https://www.ncbi.nlm.nih.gov/pubmed/21270245
http://dx.doi.org/10.2337/db10-1489
work_keys_str_mv AT vendramefrancesco commentonmeagheretalneutralizationofinterleukin16protectsnonobesediabeticmicefromautoimmunetype1diabetesbyaccl4dependentmechanismdiabetes20105928622871
AT dottafrancesco commentonmeagheretalneutralizationofinterleukin16protectsnonobesediabeticmicefromautoimmunetype1diabetesbyaccl4dependentmechanismdiabetes20105928622871